Soley Therapeutics

aid: soley-therapeutics
name: Soley Therapeutics
description: 'Soley Therapeutics is a science-first, tech-enabled drug discovery and development company headquartered in
  South San Francisco, California, using human cells as biological sensors to uncover first-in-class medicines. Its cell stress
  sensing platform captures time-resolved cellular responses across thousands of features and applies computer vision and
  machine learning to compress them into compact signatures, screening hundreds of thousands of compounds per week on proprietary
  automation and robotics. The company is advancing a lead oncology asset for acute myeloid leukemia toward an IND filing,
  a second oncology asset for solid tumors in IND-enabling studies, and non-oncology stress-reducing candidates for neurodegenerative
  and metabolic disease. Soley raised a $200M Series C in January 2026, bringing total funding to roughly $290M. The platform
  is an internal discovery engine: Soley is a therapeutics developer, not a software vendor, and publishes no public API,
  developer portal, or machine-readable specification.'
url: https://raw.githubusercontent.com/api-evangelist/soley-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
deliveryModel:
  model: unknown
  open_source: false
  commercial: false
  callable_host: false
  label: Delivery model not determined — needs a product licence on record
  confidence: low
  source:
  - none
  generated: '2026-08-28'
  method: derived
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source:
  - security
  generated: '2026-09-02'
  method: derived
specificationVersion: '0.23'
created: '2026-08-05'
modified: '2026-08-05'
tags:
- Company
- Biotechnology
- Therapeutics
- Drug Discovery
- Oncology
- Artificial Intelligence
- Machine-Learning
- Life Sciences
- Healthcare
tags_raw:
- Company
- Biotechnology
- Therapeutics
- Drug Discovery
- Oncology
- Artificial Intelligence
- Machine Learning
- Life Sciences
- Health Care
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/soley-therapeutics-domain-security.yml
- type: Website
  url: https://soleytherapeutics.com/
- type: About
  url: https://soleytherapeutics.com/about/
- type: Pipeline
  url: https://soleytherapeutics.com/pipeline/
- type: Contact
  url: https://soleytherapeutics.com/contact/
- type: GitHubOrganization
  url: https://github.com/Soley-Therapeutics
- type: SecondaryMarket
  url: https://www.hiive.com/securities/soley-therapeutics-stock
x-enrichment:
  date: '2026-08-05'
  status: minimal
  artifacts_added: 1
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: 'Soley sells therapeutics, not software - its cell stress sensing platform is an internal discovery engine - and
    no API host exists to document: wildcard DNS makes api/docs/developer subdomains resolve to the same WordPress marketing
    host whose TLS certificate covers only the apex and www, the GitHub org holds only two forks of third-party ML infrastructure
    (NVIDIA dcgm-exporter), and no npm or PyPI package exists. Note the 202s below are a SiteGround "sg-captcha: challenge"
    interstitial that answers every path including a nonsense control, so the marketing site itself was never readable by
    our probe - the no-API finding rests on the DNS, TLS, GitHub and registry evidence, not on that host.'
  evidence:
  - url: https://github.com/Soley-Therapeutics
    status: 200
  - url: https://api.github.com/orgs/soley-therapeutics/repos
    status: 200
  - url: https://registry.npmjs.org/-/v1/search?text=soley%20therapeutics
    status: 200
  - url: https://pypi.org/pypi/soley-therapeutics/json
    status: 404
  - url: https://soleytherapeutics.com/.well-known/agent-card.json
    status: 202
  - url: https://soleytherapeutics.com/openapi.json
    status: 202
  checked: '2026-08-05'